Patent Yard Sign in
Expired Canadian patentCanada

Solutions for the perfusion, preservation and reperfusion of organs

CA 2055827 C · Owner: Pasteur Merieux Serums Et Vaccins S.A. · Inventors: Menasche, Philippe

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Perfusion and preservation and/or reperfusion solutions for surgery and organ transplantation including that of the heart, a feature of which solutions is the inclusion of at least one antioxidant compound such, as a trapping agent for free oxygen radicals in, particular glutathione in the reduced state or N-acetylcysteine, said solutions possessing a zero or greatly reduced partial pressure of oxygen which is maintained substantially at this value up to the time of use. The solution is preferably presented in flexible bags impermeable to oxygen.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 19, 1991 and granted June 15, 1999. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 19, 2011.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 19, 2013.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 19, 1991
GrantedJune 15, 1999
Term endedNovember 19, 2011
Patent numberCA 2055827 C
Classification (IPC)A61K38/06 +2 more

Timeline

Timeline From CIPO dates

1992199419961998200020022004200620082010Application filedNov 19, 1991Patent grantedJune 15, 1999Term endedNov 19, 2011

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.